ResearcherTongji HospitalActive in the last 2 years
Yu Bai
Matched on OpenAlex author ID A5124164811. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2026: 2 papers
Papers 2
- USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake. Co-author DOI 10.1016/j.canlet.2026.218299↗
- Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3. Co-author DOI 10.1038/s41418-026-01665-1↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhenxiong Zhang · 2 shared papers, 2026 · strength 0.49
- Paper Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and sta… DOI 10.1038/s41418-026-01665-1↗
- Paper USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibi… DOI 10.1016/j.canlet.2026.218299↗
- Yongkang Shi · 2 shared papers, 2026 · strength 0.49
- Paper Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and sta… DOI 10.1038/s41418-026-01665-1↗
- Paper USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibi… DOI 10.1016/j.canlet.2026.218299↗
- Renyi Qin · 2 shared papers, 2026 · strength 0.49
- Paper Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and sta… DOI 10.1038/s41418-026-01665-1↗
- Paper USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibi… DOI 10.1016/j.canlet.2026.218299↗
- Min Zhou · 1 shared paper, 2026 · strength 0.26
- Shutao Pan · 1 shared paper, 2026 · strength 0.26
- Jun Gong · 1 shared paper, 2026 · strength 0.26
- Min Wang · 1 shared paper, 2026 · strength 0.26
- Chunle Zhao · 1 shared paper, 2026 · strength 0.26
- Taoyuan Yin · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.